T-cell prolymphocytic leukemia (PLL) cells were characterized by homogenously moderate CD2, CD5, and CD7, variable loss of surface CD3, moderate-to-dim CD26, heterogeneous CD25, and moderate TCL1. This evidence concerns the gene CD5 and T-cell prolymphocytic leukemia.